Ilaria Crespiatico
5PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 08, 2025
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies.Federica Malighetti, Matteo Villa, Mario Mauri
|Jan 09, 2024
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis.Ilaria Crespiatico, Mattia Zaghi, Cristina Mastini
|Jan 21, 2023
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples.Andrea Aroldi, Fabrizio Angaroni, Deborah D'Aliberti
|Sep 10, 2021
Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma.Giulia Arosio, Geeta G Sharma, Matteo Villa
|Jan 31, 2020
An Imatinib-non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization.Ilaria Crespiatico, Elisa Bossi, Filippo Brioschi
Pageof 1
Frequent Collaborators
4 joint publications
Rocco Piazza
3 joint publications
Mario Mauri
3 joint publications
Valentina Crippa
3 joint publications
Daniele Ramazzotti
2 joint publications
Luca Mologni
2 joint publications
Matteo Villa
2 joint publications
Diletta Fontana
2 joint publications
Ivan Civettini
1 joint publications
Sara Redaelli
1 joint publications
Luca Massimino
